BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Neurocampus - ECPv4.9.10//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Neurocampus
X-ORIGINAL-URL:https://www.bordeaux-neurocampus.fr/en/
X-WR-CALDESC:Events for Bordeaux Neurocampus
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231024
DTEND;VALUE=DATE:20231110
DTSTAMP:20260410T160717
CREATED:20221122T113608Z
LAST-MODIFIED:20231109T141649Z
UID:152946-1698105600-1699574399@www.bordeaux-neurocampus.fr
SUMMARY:Cajal lectures: Advanced techniques for synapse biology
DESCRIPTION:Venue: CGFB \nFree access \n\nOctober 24 – 9:00am \nCécile Charrier (Institute of Biology\, École Normale Supérieure\, France)\nMolecular mechanisms of synaptic development: insights from a human-specific gene. \nOctober 24 – 11:00am \nBrian Mac Cabe (EPFL\, Lausanne\, Swiss)\nUnknown knowns of Drosophila synapses. \nOctober 26 – 9:00am\n Noa Lipstein (LeibnizFMP\, Germany)\nSynaptic transmission in health and disease. \nOctober 26 – 11:00am\n Julie Perroy (IGF\, University of Montpellier\, France)\nMolecular dynamics at glutamatergic synapses and beyond. \nOctober 28 – 9:00am \nJosef Kittler (University College London\, UK)\nMolecular mechanism of inhibitory synapse formation and plasticity. \nOctober 30 – 9:00am \nDaniel Choquet (CNRS/University of Bordeaux\, France)\nNanoscale synapse organization and function. \nNovember 2 – 9:00am \nMarina Mikhaylova (Humboldt University \, Germany)\nCalcium and synaptic heterogeneity. \nNovember 3 – 9:00am\nRosa Paolicelli (University of Lausanne\, Swiss)\nMicroglia: key players in synapse remodeling in the healthy and diseased brain. \nNovember 3 – 11:00am \nAlfredo Kirkwood (Johns Hopkins University\, USA)\nPrinciples of Hebbian\, Pavlovian and Homeostatic synaptic plasticity. \nNovember 6 – 9:00am \nJuan Burrone (King’s College London\, UK)\nThe emergence and plasticity of inhibitory synapses: from dendrites to the axon initial segment. \nNovember 6 – 11:00am \nAxion BioSystems : Presentation \nNovember 7 – 9:00am \nNael Nadif Kasri (Radboud University Medical Center\, Netherlands)\nLeveraging spontaneous activity in human neuronal stem cell-derived neurons to model neurodevelopmental disorders. \nNovember 9 – 9:00am \nChristian Lohmann (Netherlands Institute for Neuroscience\, Netherlands)\nImaging synapse development. \nNovember 9 – 11:00am \nJulijana Gjorgjieva (Max Planck Institute for Brain Research\, Germany)\nEmergence of organization and computations at the subcellular and cellular scales. \nCourse directors\nAna Luisa Carvalho – Coimbra University\, Portugal \nMathieu Letellier – Bordeaux University\, France \nHey-Kyoung Lee – John Hopkins University.\, US \nAbout the course\nAdvanced techniques for synapse biology – CAJAL (cajal-training.org) \n
URL:https://www.bordeaux-neurocampus.fr/en/event/advanced-techniques-for-synapse-biology/
CATEGORIES:Cajal Lectures,For scientists
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20231030T113000
DTEND;TZID=Europe/Paris:20231030T113000
DTSTAMP:20260410T160717
CREATED:20230801T075849Z
LAST-MODIFIED:20231025T175546Z
UID:161713-1698665400-1698665400@www.bordeaux-neurocampus.fr
SUMMARY:Seminar - Ivan D. Montoya
DESCRIPTION:Venue: Centre Broca \n\nIvan Montoya\nNational Institute of Drug Abuse (Maryland\, United States)\nDirector\nhttps://www.researchgate.net/profile/Ivan-Montoya-8 \nInvited by Marc Auriacombe \nTitle\nNew targets and medications for stimulant use disorders \nAbstract\nThe prevalence of stimulant use disorders (StUD) is increasing worldwide. In the United States\, stimulants are associated with about 40% of the drug overdose deaths. Unfortunately\, there are no medications approved by regulatory agencies to treat StUD\, including stimulant overdose. The US National Institute on Drug Abuse (NIDA) has intensified its efforts to discover and develop medication to tear these conditions. The purpose of the presentation is to provide an overview of the new pharmacological targets and new medications that NIDA is currently investigating to treat StUD and overdose. \nBiosketch\nDr. Montoya is the Clinical Director of the Division of Therapeutics and Medical Consequences (DTMC) of the National Institute on Drug Abuse (NIDA) and Chair of the National Institutes of Health (NIH) HEAL Initiative in Therapeutics Development for Opioid and Stimulant Use Disorders. He leads a large program of research that supports the development of pharmacological and non-pharmacological treatments for Substance Use Disorders (SUDs). He has an M.D. and specialized in psychiatrist from the University of Antioquia (Colombia) and has a Master’s in Public Health (M.P.H.) from Johns Hopkins University. He completed a Post-Doctoral Fellowship at the Intramural Research Program of NIDA and was the Director of the Practice Research Network of the American Psychiatric Association. He has published extensively in the areas of etiology\, prevention\, treatment\, and medical consequences of SUDs. He is the editor of a book summarizing the science on biologics (vaccines\, monoclonal antibodies\, and enzymes) to treat SUDs and of another book focusing on the science of Cannabis Use Disorders. He has received numerous awards including the NIH Director’s Award and the Michael Morrison Award from the College on Problems of Drug Dependence (CPDD). \n
URL:https://www.bordeaux-neurocampus.fr/en/event/seminar-ivan-d-montoya/
CATEGORIES:For scientists,home-event,Impromptu seminar
END:VEVENT
END:VCALENDAR